Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population

ContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Inbal Halabi, Yardena Tenenbaum-Rakover, Lena Sagi-Dain, Ilana Koren
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582880178470912
author Inbal Halabi
Inbal Halabi
Yardena Tenenbaum-Rakover
Yardena Tenenbaum-Rakover
Lena Sagi-Dain
Lena Sagi-Dain
Lena Sagi-Dain
Ilana Koren
Ilana Koren
Ilana Koren
author_facet Inbal Halabi
Inbal Halabi
Yardena Tenenbaum-Rakover
Yardena Tenenbaum-Rakover
Lena Sagi-Dain
Lena Sagi-Dain
Lena Sagi-Dain
Ilana Koren
Ilana Koren
Ilana Koren
author_sort Inbal Halabi
collection DOAJ
description ContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even within the same family and with the same variant.ObjectiveTo report the phenotypes of five patients of Druze origin, all carrying the same autosomal recessive pathogenic variant in the WFS1 gene.Patients & methodsFive patients belonging to three core families were enrolled. Clinical, biochemical, and genetic data were retrieved retrospectively from their medical files.ResultsAll five patients carried the same previously reported homozygous WFS1 pathogenic variant: c.2649del, p.Phe884fs. In all patients, the first presentation was DM at a mean age of 5.2 years (range 4–7), diagnosed initially as type 1 DM with negative anti-pancreatic autoantibodies, and all were treated with insulin by either pump or multiple injections. All five patients had OA that appeared at a mean age of 12.3 years (range 4–30). Three had hearing loss and neurological involvement, and none had diabetes insipidus. One patient was treated with a glucagon-like peptide 1 receptor agonist with a good response.ConclusionsThis is the first report of a founder pathogenic variant in the WFS1 gene in the Druze population in Israel. Our findings imply that molecular analysis is warranted in children presenting with DM and negative pancreatic antibodies. The identified variant should be considered for genetic testing in individuals of Druze ancestry diagnosed with young-onset non-autoimmune diabetes. Early diagnosis of WS is important for therapeutic approaches, especially since novel medications are becoming available.
format Article
id doaj-art-aa3130497f0348949749105a44c0266f
institution Kabale University
issn 2296-2360
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-aa3130497f0348949749105a44c0266f2025-01-29T06:46:11ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-01-011310.3389/fped.2025.15258461525846Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze populationInbal Halabi0Inbal Halabi1Yardena Tenenbaum-Rakover2Yardena Tenenbaum-Rakover3Lena Sagi-Dain4Lena Sagi-Dain5Lena Sagi-Dain6Ilana Koren7Ilana Koren8Ilana Koren9Pediatric Endocrine Unit, Carmel Medical Center, Haifa, IsraelClalit Health Services, Haifa, IsraelChildren’s Endocrinology Consulting Center, Clalit Health Services, Afula, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelClalit Health Services, Haifa, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelGenetic Institute, Carmel Medical Center, Haifa, IsraelPediatric Endocrine Unit, Carmel Medical Center, Haifa, IsraelClalit Health Services, Haifa, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even within the same family and with the same variant.ObjectiveTo report the phenotypes of five patients of Druze origin, all carrying the same autosomal recessive pathogenic variant in the WFS1 gene.Patients & methodsFive patients belonging to three core families were enrolled. Clinical, biochemical, and genetic data were retrieved retrospectively from their medical files.ResultsAll five patients carried the same previously reported homozygous WFS1 pathogenic variant: c.2649del, p.Phe884fs. In all patients, the first presentation was DM at a mean age of 5.2 years (range 4–7), diagnosed initially as type 1 DM with negative anti-pancreatic autoantibodies, and all were treated with insulin by either pump or multiple injections. All five patients had OA that appeared at a mean age of 12.3 years (range 4–30). Three had hearing loss and neurological involvement, and none had diabetes insipidus. One patient was treated with a glucagon-like peptide 1 receptor agonist with a good response.ConclusionsThis is the first report of a founder pathogenic variant in the WFS1 gene in the Druze population in Israel. Our findings imply that molecular analysis is warranted in children presenting with DM and negative pancreatic antibodies. The identified variant should be considered for genetic testing in individuals of Druze ancestry diagnosed with young-onset non-autoimmune diabetes. Early diagnosis of WS is important for therapeutic approaches, especially since novel medications are becoming available.https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/fullWolfram syndromediabetes mellitusoptic atrophyendoplasmic reticulumtype 1 diabetes mellitusdiabetic ketoacidosis
spellingShingle Inbal Halabi
Inbal Halabi
Yardena Tenenbaum-Rakover
Yardena Tenenbaum-Rakover
Lena Sagi-Dain
Lena Sagi-Dain
Lena Sagi-Dain
Ilana Koren
Ilana Koren
Ilana Koren
Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
Frontiers in Pediatrics
Wolfram syndrome
diabetes mellitus
optic atrophy
endoplasmic reticulum
type 1 diabetes mellitus
diabetic ketoacidosis
title Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
title_full Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
title_fullStr Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
title_full_unstemmed Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
title_short Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
title_sort identification of a pathogenic founder variant in the wfs1 gene that causes wolfram syndrome in the druze population
topic Wolfram syndrome
diabetes mellitus
optic atrophy
endoplasmic reticulum
type 1 diabetes mellitus
diabetic ketoacidosis
url https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/full
work_keys_str_mv AT inbalhalabi identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT inbalhalabi identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT yardenatenenbaumrakover identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT yardenatenenbaumrakover identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation
AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation